Cargando…
International platform trials: as diseases cross borders, so should trials
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036126/ https://www.ncbi.nlm.nih.gov/pubmed/36966801 http://dx.doi.org/10.1016/S1473-3099(23)00193-7 |
| _version_ | 1784911576991531008 |
|---|---|
| author | Saito, Hiroki |
| author_facet | Saito, Hiroki |
| author_sort | Saito, Hiroki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10036126 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100361262023-03-24 International platform trials: as diseases cross borders, so should trials Saito, Hiroki Lancet Infect Dis Correspondence Elsevier Ltd. 2023-05 2023-03-23 /pmc/articles/PMC10036126/ /pubmed/36966801 http://dx.doi.org/10.1016/S1473-3099(23)00193-7 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Saito, Hiroki International platform trials: as diseases cross borders, so should trials |
| title | International platform trials: as diseases cross borders, so should trials |
| title_full | International platform trials: as diseases cross borders, so should trials |
| title_fullStr | International platform trials: as diseases cross borders, so should trials |
| title_full_unstemmed | International platform trials: as diseases cross borders, so should trials |
| title_short | International platform trials: as diseases cross borders, so should trials |
| title_sort | international platform trials: as diseases cross borders, so should trials |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036126/ https://www.ncbi.nlm.nih.gov/pubmed/36966801 http://dx.doi.org/10.1016/S1473-3099(23)00193-7 |
| work_keys_str_mv | AT saitohiroki internationalplatformtrialsasdiseasescrossborderssoshouldtrials AT internationalplatformtrialsasdiseasescrossborderssoshouldtrials |